| Recruiting | 1 | 830 | Europe, Canada, Japan, US, RoW | MK-1084, Pembrolizumab, KEYTRUDA®, MK-3475, carboplatin, pemetrexed, cetuximab, oxaliplatin, leucovorin, 5-fluorouracil | Merck Sharp & Dohme LLC | Advanced Solid Tumors | 08/26 | 08/26 | | |
| Recruiting | 1 | 178 | Europe, Canada, US | MK-0472, Pembrolizumab, MK-3475, Keytruda®, MK-1084 | Merck Sharp & Dohme LLC | Metastatic Solid Tumors, Advanced Solid Tumors | 02/28 | 02/28 | | |